Brookdale Senior Living backs its board against Ortelius' challenge

Brookdale Senior Living is urging shareholders to support its current board nominees against a challenge from Ortelius Advisors, which owns approximately 1% of the company; the vote will take place at the annual meeting on July 11, 2025. Brookdale defends its board's experience and highlights recent performance improvements, including positive adjusted free cash flow, while criticizing Ortelius' nominees as lacking relevant expertise. This proxy battle unfolds as Brookdale reported a larger-than-expected Q1 2025 loss per share, though the company raised its adjusted EBITDA guidance for 2025 and RBC Capital Markets increased its price target, reflecting a mixed outlook amid a CEO transition.

Analysis

Brookdale Senior Living (BKD) is currently navigating a significant corporate governance challenge from activist investor Ortelius Advisors, L.P., which holds approximately 1% of BKD's shares and is proposing six director nominees for the July 11, 2025, annual meeting. Brookdale's management is actively defending its current board, emphasizing a recent refreshment with four new directors possessing expertise in real estate, healthcare, operations, and senior housing, contributing to an average board tenure of less than four years among its eight nominees, seven of whom are independent. The company highlights recent operational improvements, such as positive adjusted free cash flow and an increase in consolidated weighted average occupancy year-over-year, and asserts it has outperformed its peer, Sonida Senior Living, Inc. This defense occurs amidst concerning financial indicators from InvestingPro, including a significant debt burden reflected by a 0.79 debt-to-capital ratio, a rapid cash burn rate, and a constrained current ratio of 0.82, despite a 4.1% revenue growth. Brookdale's Q1 2025 results revealed a larger-than-expected loss per share of -$0.28, compared to an anticipated -$0.13, and revenue of $813.86 million narrowly missed forecasts. Nevertheless, the company raised its full-year 2025 adjusted EBITDA guidance to $440-$450 million, and RBC Capital Markets increased its price target on BKD to $9.00, maintaining an Outperform rating. The ongoing CEO transition introduces further uncertainty, and InvestingPro analysis suggests BKD shares are trading above their Fair Value, warranting careful consideration of the company's strategic direction and financial stability.

Key Decisions for Investors

• Investors should critically evaluate the competing board nominations from Brookdale and Ortelius Advisors, weighing the incumbent board's recent refreshment and operational arguments against the activist's push for governance changes ahead of the July 2025 annual meeting.
• Monitor closely Brookdale's progress towards its increased 2025 adjusted EBITDA target, as improved cash flow generation is crucial for addressing concerns related to its substantial debt load, cash consumption, and liquidity position.
• Consider the current valuation, noted by InvestingPro as potentially above Fair Value, in conjunction with the mixed Q1 2025 earnings, the ongoing CEO transition, and the potential impact of the proxy contest outcome on future strategy and shareholder returns.